Louis Navellier

Louis Navellier

Editor, Growth Investor
New York Times
An icon among growth stock investors

About Louis Navellier

Louis Navellier is one of Wall Street’s renowned growth investors. Providing investment advice to tens of thousands of investors for more than four decades, he has earned a reputation as a savvy stock picker and unrivaled portfolio manager.

Over his investing career, Louis Navellier has established one of the most exceptional long-term track records of any financial newsletter editor in America, and he offers a wide range of simple yet powerful tools that can help all investors to significantly beat the market.

His popular Growth Investor advisory service, established in 1998, has outperformed the S&P 500 by a margin of 2-to-1.

Navellier continues to build on those stellar records, and while his methodology is rigorous and complex, his goal has been simple since the beginning: uncover the market’s best growth stocks and help investors beat the market with less risk. Today, he helps individual investors across the nation and across the globe achieve their financial dreams through his unique newsletter services.

The New York Times called Mr. Navellier “an icon among growth stock investors,” and the media frequently turns to Louis for his expert opinion. He appears regularly on CNBC and Fox Business News and is frequently quoted by MarketWatch, Bloomberg and The Wall Street Journal.

Navellier is an accomplished Wall Street insider as well. He and his team of professional analysts and staff manage nearly $1 billion in high-net worth funds and institutional accounts through his management company, Navellier & Associates.

Louis Navellier also has a YouTube channel, Navellier Market Buzz, where he posts regular video updates discussing the stock market. He is the author of the bestselling books, The Little Book That Makes You Rich and The Sacred Truths of Investing.

Premium Services

Louis Navellier’s Growth Investor provides an expert’s take on the latest market trends and opportunities. Then Louis shares his picks of High-Growth Investments and Elite Dividend Payers — complete with volatility ratings and buy-below prices.

  • Stocks (Mid- to Large-Cap)

  • Conservative

  • Monthly trades

Learn More

Already a member? Login here

If you want growth, you’ve got to look at smaller up-and-comers that aren’t as well-known... yet. Louis Navellier’s Breakthrough Stocks lets you participate in high-quality small-caps — according to your personal risk tolerance.

  • Stocks (Small to Mid-Cap)

  • Moderate to Aggressive

  • Monthly trades

Learn More

Already a member? Login here

Accelerated Profits uses Louis Navellier’s proprietary stock-rating system to identify High Velocity and Ultimate Growth Trades. By combining the “one-two punch” of strong momentum and fundamentals with a more frequent trading schedule, you get significant returns... in a fraction of the time.

  • Stocks (Large-Cap)

  • Aggressive

  • Weekly trades

Learn More

Already a member? Login here

Louis Navellier’s Platinum Growth combines the top-notch investing strategies of Growth Investor and Breakthrough Stocks with the faster pace of Accelerated Profits — all in a powerful new way that could improve your results 10-fold or better.

  • Stocks

  • Conservative to Aggressive

  • Weekly and monthly trades

Learn More

Already a member? Login here

Recent Articles

Weekly Upgrades and Downgrades

By Louis Navellier, Editor, Growth Investor

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 87 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

The Bright Future Behind Genomic Sequencing

By

Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here's what investors need to know now.

What the Fed’s Latest Decision Means for the Market

By

After the Federal Reserve released its latest decision, what does it mean for both Wall Street and Main Street? Let's take a closer look.

Why Now is a Great Time to Invest in Stocks

By

After a choppy last year on both Wall Street and Main Street, here is why now is a fantastic time to invest in stocks.

Weekly Upgrades and Downgrades

By Louis Navellier, Editor, Growth Investor

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 190 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

3 Ways to Invest in the Microgridification Trend

By Louis Navellier, Editor, Growth Investor

Efficient and reliable, the microgrid trend is here to stay. These three stocks will help you capitalize on it.

These 5 Hot IPOs Post Weak Q4 Results

By

After a handful of companies had their initial public offering (IPO), let's take a deeper look at each of their first quarterly reports.

Best Stocks for 2021: Fiverr Stock Investors Should Should See More Gains

By Louis Navellier, Editor, Growth Investor

FVRR stock might not be the first thing people think of in the e-commerce bull market, but investors should expect more gains from Fiverr.

Are Chinese Stocks a Buy on Weakness?

By Louis Navellier, Editor, Growth Investor

Chinese stocks have had a tough go of it recently. To differentiate between the duds and the winners, we have to look at the fundamentals.

Weekly Upgrades and Downgrades

By Louis Navellier, Editor, Growth Investor

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 93 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.

Load More